Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test

Virna M G De Benedetti, Paolo Radice, Patrizia Mondini, Giovanbattista Spatti, Alberto Conti, Maria T. Illeni, Maria A. Caligo, Giovanna Cipollini, Generoso Bevilaqua, Silvana Pilotti, Marco A. Pierotti

Research output: Contribution to journalArticle

Abstract

The most common mutations in the familial breast and ovarian cancer susceptibility gene BRCA1 are frameshift and nonsense mutations, which lead to the synthesis of truncated proteins. On this ground, we have analysed BRCA1 exon 11, which includes about 61% of coding region, in germline DNA from 70 Italian breast and/or ovarian cancer patients, using the protein truncation test (PTT). BRCA1 mutations were identified in nine of 29 (~ 31%) patients with a family history of cancer and in three of 41 (~ 7%) women with early-onset breast carcinomas, and were subsequently characterized by sequence analysis. In addition, BRCA1 mutations were also detected in six affected relatives of two positive index cases. The observed frequencies of mutations were not significantly different from those expected on the basis of the phenotypic characteristics of patients and their families, indicating that PTT is a rapid and sensitive method that can be used for a first BRCA1 mutational screening. The histological findings in BRCA1 mutated cases showed that eight of nine (~ 89%) breast carcinomas were of grade III and nine of 9 (100%) ovarian carcinomas were of the endometrioid type (eight of grade III and one of grade II). This suggests that specific histological characteristics may represent additional criteria for selection of cases eligible to BRCA1 mutational analysis.

Original languageEnglish
Pages (from-to)1353-1357
Number of pages5
JournalOncogene
Volume13
Issue number6
Publication statusPublished - 1996

Fingerprint

BRCA1 Gene
Ovarian Neoplasms
Exons
Breast Neoplasms
Mutation
Endometrioid Carcinoma
Frameshift Mutation
Proteins
Nonsense Codon
Neoplasm Genes
Mutation Rate
Patient Selection
Sequence Analysis
DNA
Neoplasms

Keywords

  • BRCA1
  • Breast cancer
  • Hereditary tumours
  • Ovarian cancer
  • PTT

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

De Benedetti, V. M. G., Radice, P., Mondini, P., Spatti, G., Conti, A., Illeni, M. T., ... Pierotti, M. A. (1996). Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test. Oncogene, 13(6), 1353-1357.

Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test. / De Benedetti, Virna M G; Radice, Paolo; Mondini, Patrizia; Spatti, Giovanbattista; Conti, Alberto; Illeni, Maria T.; Caligo, Maria A.; Cipollini, Giovanna; Bevilaqua, Generoso; Pilotti, Silvana; Pierotti, Marco A.

In: Oncogene, Vol. 13, No. 6, 1996, p. 1353-1357.

Research output: Contribution to journalArticle

De Benedetti, VMG, Radice, P, Mondini, P, Spatti, G, Conti, A, Illeni, MT, Caligo, MA, Cipollini, G, Bevilaqua, G, Pilotti, S & Pierotti, MA 1996, 'Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test', Oncogene, vol. 13, no. 6, pp. 1353-1357.
De Benedetti, Virna M G ; Radice, Paolo ; Mondini, Patrizia ; Spatti, Giovanbattista ; Conti, Alberto ; Illeni, Maria T. ; Caligo, Maria A. ; Cipollini, Giovanna ; Bevilaqua, Generoso ; Pilotti, Silvana ; Pierotti, Marco A. / Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test. In: Oncogene. 1996 ; Vol. 13, No. 6. pp. 1353-1357.
@article{4ef286620e5e47d0b8098854003c9992,
title = "Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test",
abstract = "The most common mutations in the familial breast and ovarian cancer susceptibility gene BRCA1 are frameshift and nonsense mutations, which lead to the synthesis of truncated proteins. On this ground, we have analysed BRCA1 exon 11, which includes about 61{\%} of coding region, in germline DNA from 70 Italian breast and/or ovarian cancer patients, using the protein truncation test (PTT). BRCA1 mutations were identified in nine of 29 (~ 31{\%}) patients with a family history of cancer and in three of 41 (~ 7{\%}) women with early-onset breast carcinomas, and were subsequently characterized by sequence analysis. In addition, BRCA1 mutations were also detected in six affected relatives of two positive index cases. The observed frequencies of mutations were not significantly different from those expected on the basis of the phenotypic characteristics of patients and their families, indicating that PTT is a rapid and sensitive method that can be used for a first BRCA1 mutational screening. The histological findings in BRCA1 mutated cases showed that eight of nine (~ 89{\%}) breast carcinomas were of grade III and nine of 9 (100{\%}) ovarian carcinomas were of the endometrioid type (eight of grade III and one of grade II). This suggests that specific histological characteristics may represent additional criteria for selection of cases eligible to BRCA1 mutational analysis.",
keywords = "BRCA1, Breast cancer, Hereditary tumours, Ovarian cancer, PTT",
author = "{De Benedetti}, {Virna M G} and Paolo Radice and Patrizia Mondini and Giovanbattista Spatti and Alberto Conti and Illeni, {Maria T.} and Caligo, {Maria A.} and Giovanna Cipollini and Generoso Bevilaqua and Silvana Pilotti and Pierotti, {Marco A.}",
year = "1996",
language = "English",
volume = "13",
pages = "1353--1357",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test

AU - De Benedetti, Virna M G

AU - Radice, Paolo

AU - Mondini, Patrizia

AU - Spatti, Giovanbattista

AU - Conti, Alberto

AU - Illeni, Maria T.

AU - Caligo, Maria A.

AU - Cipollini, Giovanna

AU - Bevilaqua, Generoso

AU - Pilotti, Silvana

AU - Pierotti, Marco A.

PY - 1996

Y1 - 1996

N2 - The most common mutations in the familial breast and ovarian cancer susceptibility gene BRCA1 are frameshift and nonsense mutations, which lead to the synthesis of truncated proteins. On this ground, we have analysed BRCA1 exon 11, which includes about 61% of coding region, in germline DNA from 70 Italian breast and/or ovarian cancer patients, using the protein truncation test (PTT). BRCA1 mutations were identified in nine of 29 (~ 31%) patients with a family history of cancer and in three of 41 (~ 7%) women with early-onset breast carcinomas, and were subsequently characterized by sequence analysis. In addition, BRCA1 mutations were also detected in six affected relatives of two positive index cases. The observed frequencies of mutations were not significantly different from those expected on the basis of the phenotypic characteristics of patients and their families, indicating that PTT is a rapid and sensitive method that can be used for a first BRCA1 mutational screening. The histological findings in BRCA1 mutated cases showed that eight of nine (~ 89%) breast carcinomas were of grade III and nine of 9 (100%) ovarian carcinomas were of the endometrioid type (eight of grade III and one of grade II). This suggests that specific histological characteristics may represent additional criteria for selection of cases eligible to BRCA1 mutational analysis.

AB - The most common mutations in the familial breast and ovarian cancer susceptibility gene BRCA1 are frameshift and nonsense mutations, which lead to the synthesis of truncated proteins. On this ground, we have analysed BRCA1 exon 11, which includes about 61% of coding region, in germline DNA from 70 Italian breast and/or ovarian cancer patients, using the protein truncation test (PTT). BRCA1 mutations were identified in nine of 29 (~ 31%) patients with a family history of cancer and in three of 41 (~ 7%) women with early-onset breast carcinomas, and were subsequently characterized by sequence analysis. In addition, BRCA1 mutations were also detected in six affected relatives of two positive index cases. The observed frequencies of mutations were not significantly different from those expected on the basis of the phenotypic characteristics of patients and their families, indicating that PTT is a rapid and sensitive method that can be used for a first BRCA1 mutational screening. The histological findings in BRCA1 mutated cases showed that eight of nine (~ 89%) breast carcinomas were of grade III and nine of 9 (100%) ovarian carcinomas were of the endometrioid type (eight of grade III and one of grade II). This suggests that specific histological characteristics may represent additional criteria for selection of cases eligible to BRCA1 mutational analysis.

KW - BRCA1

KW - Breast cancer

KW - Hereditary tumours

KW - Ovarian cancer

KW - PTT

UR - http://www.scopus.com/inward/record.url?scp=10244261615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10244261615&partnerID=8YFLogxK

M3 - Article

C2 - 8808710

AN - SCOPUS:10244261615

VL - 13

SP - 1353

EP - 1357

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 6

ER -